Folgen
Abinaya Badri
Abinaya Badri
Organism Engineer, Ginkgo Bioworks
Bestätigte E-Mail-Adresse bei ginkgobioworks.com
Titel
Zitiert von
Zitiert von
Jahr
The road to animal-free glycosaminoglycan production: current efforts and bottlenecks
A Badri, A Williams, RJ Linhardt, MAG Koffas
Current opinion in biotechnology 53, 85-92, 2018
802018
Complete biosynthesis of a sulfated chondroitin in Escherichia coli
A Badri, A Williams, A Awofiranye, P Datta, K Xia, W He, K Fraser, ...
Nature Communications 12 (1), 1389, 2021
612021
Metabolic engineering for production of functional polysaccharides
C Schilling, A Badri, V Sieber, M Koffas, J Schmid
Current Opinion in Biotechnology 66, 44-51, 2020
392020
Increased 3′‐Phosphoadenosine‐5′‐phosphosulfate Levels in Engineered Escherichia coli Cell Lysate Facilitate the In Vitro Synthesis of Chondroitin Sulfate A
A Badri, A Williams, K Xia, RJ Linhardt, MAG Koffas
Biotechnology Journal 14 (9), 1800436, 2019
302019
Uncovering Novel Pathways for Enhancing Hyaluronan Synthesis in Recombinant Lactococcus lactis: Genome-Scale Metabolic Modeling and Experimental …
A Badri, K Raman, G Jayaraman
Processes 7 (6), 343, 2019
182019
Fabrication of homotypic neural ribbons as a multiplex platform optimized for spinal cord delivery
ZT Olmsted, C Stigliano, A Badri, F Zhang, A Williams, MAG Koffas, Y Xie, ...
Scientific Reports 10 (1), 12939, 2020
162020
Biochemical characterization of inducible ‘Reductase’component of benzoate dioxygenase and phthalate isomer dioxygenases from Pseudomonas aeruginosa strain PP4
R Karandikar, A Badri, PS Phale
Applied biochemistry and biotechnology 177, 318-333, 2015
112015
N-glycolyl chondroitin synthesis using metabolically engineered E. coli
AE Awofiranye, SN Baytas, K Xia, A Badri, W He, A Varki, M Koffas, ...
AMB Express 10, 1-9, 2020
92020
Modular optimization in metabolic engineering
M Wong, A Badri, C Gasparis, G Belfort, M Koffas
Critical Reviews in Biochemistry and Molecular Biology 56 (6), 587-602, 2021
62021
In silico approaches to metabolic engineering
A Badri, A Srinivasan, K Raman
Current developments in biotechnology and bioengineering, 161-200, 2017
32017
Engineering in Vivo Sulfation in Escherichia Coli for the Complete Biosynthesis of Sulfated Glycosaminoglycans
A Badri
Rensselaer Polytechnic Institute, 2020
12020
Recombinant microorganisms for in vivo production of sulfated glycosaminoglycans
A Badri, MAG KOFFAS, RJ Linhardt, AJ Williams
US Patent App. 17/641,675, 2022
2022
Microbial Synthesis of Chondroitin Sulfates and N-Glycolyl Chondroitin Using Engineered Escherichia coli.
A Awofiranye, A Badri, AJ Williams, K Xia, P Datta, K Fraser, W He, ...
2021 AIChE Annual Meeting, 2021
2021
Outside Back Cover: Biotechnology Journal 9/2019
A Badri, A Williams, K Xia, RJ Linhardt, MAG Koffas
Biotechnology Journal 14 (9), 1970095, 2019
2019
Engineering sulfate donor accumulation in Escherichia coli: Improved in vitro chondroitin sulfate biotransformation and a step towards in vivo microbial production
A Badri, R Linhardt, M Koffas
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019
2019
Engineering sulfate donor accumulation in Escherichia coli for synthesis of sulfated glycosaminoglycans
A Badri, A Williams, R Linhardt, M Koffas, K Xia
2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–16